Vaccine Development and Global Health
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 146
Special Issue Editors
Interests: infectious diseases; pharmacovigilance; COVID-19 pandemic; pharmacotherapy; biotechnology drugs
Special Issues, Collections and Topics in MDPI journals
Interests: internal diseases; metabolic disorders; arterial hypertension; public health
Interests: pharmacology; pharmacoeconomics; medical and drug databases; quality of life; EBM; RWE; therapy costs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Facilitating vaccine development and global health is essential in protecting humans and animals from a range of diseases. Novel and proactively designed development, regulatory, and policy approaches are needed to deliver many vaccines and help sustain current vaccine programs successfully. With rates of vaccine-preventable diseases such as measles and polio rising, the gaps in immunization indicate more significant global vulnerabilities to disease outbreaks. The vital role of vaccines in responding to COVID-19 underscores the relevance of strong and equitable immunization programs and the need for novel vaccine development, such as multi-pathogen combination vaccines, e.g., more than one vaccine in the same injection to tackle multiple diseases.
This approach is compelling because it could substantially increase adherence to vaccination schedules through easier delivery. This Special Issue will discuss topics, advantages, and potential challenges of issues such as vaccine delivery, vaccination schedules, routes of administration, and the health impact. Ways to potentially increase good vaccine outcomes, including a more significant and equitable global impact to improve health and economic value, will be considered.
Dr. Anna Paczkowska
Dr. Karolina Hoffmann
Dr. Krzysztof Kus
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- next-generation vaccines
- clinical efficacy of vaccines
- vaccine safety
- treatment methods for civilization diseases
- public health
- prevention of civilization diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
